In vitro antitumor activity of cyanidin-3-O-beta-glucopyranoside

Chemotherapy. 2005 Oct;51(6):332-5. doi: 10.1159/000088956. Epub 2005 Oct 13.

Abstract

Background: Little is currently known regarding the cancer-preventive potential of cyanidin-3-O-beta-glucopyranoside (Cy-g) apart from its antioxidant activity.

Methods: We tested Cy-g on Jurkat and HL-60 leukemia cell lines and, to help elucidate whether the effects of Cy-g are specific for cancer cells, also on normal T lymphocytes.

Results: Cy-g induced apoptosis in all three cell systems, and this indicated that Cy-g was not selective towards leukemia cells. Moreover, Cy-g caused HL-60 differentiation. The induction of apoptosis and cytodifferentiation involved different proteins, thus suggesting that Cy-g-induced apoptosis and cytodifferentiation are two distinct events.

Conclusions: Although obtained in vitro, our findings indicate that Cy-g possesses some interesting biological properties that should encourage further investigation as regards its chemotherapeutic potential.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Analysis of Variance
  • Anthocyanins / pharmacology*
  • Antineoplastic Agents, Phytogenic / pharmacology*
  • Apoptosis / drug effects
  • Cell Differentiation / drug effects
  • HL-60 Cells
  • Humans
  • In Vitro Techniques
  • Jurkat Cells
  • T-Lymphocytes / drug effects

Substances

  • Anthocyanins
  • Antineoplastic Agents, Phytogenic
  • cyanidin-3-O-beta-glucopyranoside